Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)
Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)
This is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and other advanced solid tumors.
Inclusion Criteria:
Exclusion Criteria:
Other protocol defined inclusion/exclusion criteria applies.
Clinical.Trials@bms.com855-907-3286
Bellflower, California 90706, United States
000-000-0000
Saint Paul, Minnesota 55101, United States
Dallas, Texas 75246, United States
727-216-1143
507-284-2511
531-329-3667
888-542-2525
901-683-0055
214-370-1000
214-370-1000
214-370-1000